- Home
- Publications
- Publication Search
- Publication Details
Title
Ring Closure Strategy Leads to Potent RIPK3 Inhibitors
Authors
Keywords
Cell death, Inflammation, Necroptosis, RIPK1, RIPK3, Kinase
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages 113327
Publisher
Elsevier BV
Online
2021-03-09
DOI
10.1016/j.ejmech.2021.113327
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
- (2020) Lauren Mifflin et al. NATURE REVIEWS DRUG DISCOVERY
- N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy
- (2019) Hao Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage
- (2019) Amy C. Hart et al. ACS Medicinal Chemistry Letters
- Structural optimization of aminopyrimidine-based CXCR4 antagonists
- (2019) Fang Zhu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Uncovering human mixed lineage kinase domain-like activation in necroptosis
- (2019) Cristina D Guibao et al. Future Medicinal Chemistry
- Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays
- (2018) Wenfeng Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Necroptosis: a regulated inflammatory mode of cell death
- (2018) Yogesh K. Dhuriya et al. Journal of Neuroinflammation
- Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury
- (2018) Hsiao-Huei Chen et al. Neural Regeneration Research
- Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel
- (2018) Pamela A. Haile et al. ACS Medicinal Chemistry Letters
- The Structural Basis of Necroptotic Cell Death Signaling
- (2018) Emma J. Petrie et al. TRENDS IN BIOCHEMICAL SCIENCES
- Necroptosis activation in Alzheimer's disease
- (2017) Antonella Caccamo et al. NATURE NEUROSCIENCE
- The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase
- (2016) Pamela A. Haile et al. JOURNAL OF MEDICINAL CHEMISTRY
- Necroptosis in development, inflammation and disease
- (2016) Ricardo Weinlich et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- In Vitro Metabolic Stability and Permeability of Gymnemagenin and Its In Vivo Pharmacokinetic Correlation in Rats – A Pilot Study
- (2016) Rammohan Bera et al. PLANTA MEDICA
- Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
- (2016) Heng Yang et al. OncoImmunology
- Necroptosis and its role in inflammation
- (2015) Manolis Pasparakis et al. NATURE
- A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
- (2015) A Fauster et al. Cell Death & Disease
- Activation of Necroptosis in Multiple Sclerosis
- (2015) Dimitry Ofengeim et al. Cell Reports
- Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice
- (2014) S. B. Berger et al. JOURNAL OF IMMUNOLOGY
- RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
- (2014) Pratyusha Mandal et al. MOLECULAR CELL
- Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3
- (2014) Huayi Wang et al. MOLECULAR CELL
- The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury
- (2014) J-X Li et al. Cell Death & Disease
- Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death
- (2013) Xin Chen et al. CELL RESEARCH
- The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
- (2013) James M. Murphy et al. IMMUNITY
- Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
- (2013) Zhenyu Cai et al. NATURE CELL BIOLOGY
- Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death
- (2013) Dimitry Ofengeim et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Structural Insights into RIP3-Mediated Necroptotic Signaling
- (2013) Tian Xie et al. Cell Reports
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
- (2012) Liming Sun et al. CELL
- Unknown
- (2012) Andreas Linkermann et al. MOLECULAR MEDICINE
- Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis
- (2012) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome
- (2011) Linde Duprez et al. IMMUNITY
- FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation
- (2011) Patrick-Simon Welz et al. NATURE
- Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway
- (2011) S. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular mechanisms of necroptosis: an ordered cellular explosion
- (2010) Peter Vandenabeele et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
- (2009) YoungSik Cho et al. CELL
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
- (2009) Sudan He et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now